The results showed that FUBP1 and RAB2A are expressed in several types of nasopharyngeal epithelial cells, including FOXN4+ cells, squamous cells, ciliated cells, and secretory cells, in the upper respiratory tract of COVID-19 patients, especially the vRNA+ group (Fig. 4c,d). Here, RAB2A is linked to COVID-19.